Evidence map›Paper›PMID 12682118›Full record

ArticleJournal of clinical microbiology2003

Quantitative detection of Moraxella catarrhalis in nasopharyngeal secretions by real-time PCR.

Oliver Greiner, Philip J R Day, Martin Altwegg, David Nadal

Open access · greenAbstract readComparative StudyEvaluation Study
In one paragraph

Article in Journal of clinical microbiology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 81 citations in OpenAlex.

  1. Antibiotics for acute laryngitis in adults.The Cochrane database of systematic reviews · 2015
    Pooled it
  2. Trial
  3. SputumInternational journal of chronic obstructive pulmonary disease · 2019
    Trial
  4. Trial
  5. Trial
  6. Establishment and clinical application of a rapid RPA-LFS assay for detectingFrontiers in cellular and infection microbiology · 2026
    Article
  7. Article
  8. Article
  9. mBio · 2023
    Article
  10. Aptasensor for the Detection ofBioengineering (Basel, Switzerland) · 2023
    Article
  11. Rapid and reliable diagnosis ofFrontiers in bioengineering and biotechnology · 2023
    Article
  12. Article
  13. Article
  14. Rhinovirus increasesFrontiers in cellular and infection microbiology · 2022
    Article
  15. Article
  16. Article
  17. Observational
  18. Evaluation of a stepwise approach using microbiota analysis, species-specific qPCRs and culture for the diagnosis of lower respiratory tract infections.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2019
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Oliver GreinerDivision of Infectious Diseases, University Children's Hospital of Zurich, CH-8032 Zurich, Switzerland.
Philip J R Day
Martin Altwegg
David Nadal
Office of Infectious Diseases · USUniversity Children's Hospital Zurich · CHUniversity of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The recognition of Moraxella catarrhalis as an important cause of respiratory tract infections has been protracted, mainly because it is a frequent commensal organism of the upper respiratory tract and the diagnostic sensitivity of blood or pleural fluid culture is low. Given that the amount of M. catarrhalis bacteria in the upper respiratory tract may change during infection, quantification of these bacteria in nasopharyngeal secretions (NPSs) by real-time PCR may offer a suitable diagnostic approach. Using primers and a fluorescent probe specific for the copB outer membrane protein gene, we detected DNA from serial dilutions of M. catarrhalis cells corresponding to 1 to 10(6) cells. Importantly, there was no difference in the amplification efficiency when the same DNA was mixed with DNA from NPSs devoid of M. catarrhalis. The specificity of the reaction was further confirmed by the lack of amplification of DNAs from other Moraxella species, nontypeable Haemophilus influenzae, H. influenzae type b, Streptococcus pneumoniae, Streptococcus oralis, Streptococcus pyogenes, Bordetella pertussis, Corynebacterium diphtheriae, and various Neisseria species. The assay applied to NPSs from 184 patients with respiratory tract infections performed with a sensitivity of 100% and a specificity of up to 98% compared to the culture results. The numbers of M. catarrhalis organisms detected by real-time PCR correlated with the numbers detected by semiquantitative culture. This real-time PCR assay targeting the copB outer membrane protein gene provided a sensitive and reliable means for the rapid detection and quantification of M. catarrhalis in NPSs; may serve as a tool to study changes in the amounts of M. catarrhalis during lower respiratory tract infections or following vaccination against S. pneumoniae, H. influenzae, or N. meningitidis; and may be applied to other clinical samples.

Indexed as

Bacterial Outer Membrane ProteinsChildChild, PreschoolCulture MediaDNA, BacterialGram-Negative Bacterial InfectionsHumansMoraxella catarrhalisNasopharynxPolymerase Chain ReactionRespiratory Tract InfectionsSensitivity and SpecificityBacterial Outer Membrane ProteinsCopB protein, MoraxellaCulture MediaDNA, Bacterial

Identifiers

PMID12682118
PMCPMC153888
OpenAlexW2144808579

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.